SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (11162)11/15/1997 3:56:00 PM
From: Andrew H  Respond to of 32384
 
>>Clinically, LGND is set to start Phase III. However, they have many promising trials and I'm not sure where psoriasis is on their priority list (Phase III trials are very expensive).<<

I certainly hope psoriasis trials are high on their priority list--it is certainly a far larger market than KS, CTCL or APL.